Type 1 diabetes

The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes

DiabetologiaPublished Secondary analysis of the DPT-1 trial

Authors' conclusion

Our data indicate that during progression to stage 3 type 1 diabetes, rates of change in declining glucose and insulin sensitivity are not significantly different between progressors aged <14 years and progressors aged ≥14 years. These data suggest there is a predictable course of declining metabolic function during the progression to type 1 diabetes that is not influenced by age.

Study context

Population
Autoantibody-positive participants followed longitudinally in DPT-1 who progressed to stage 3 T1Dautoantibody-positive
Participants
658 participants
Comparison
Progressors aged <14 years vs progressors aged ≥14 years
Primary endpoint
Yearly rate of decline in beta cell glucose sensitivity and insulin sensitivity (OGTT modelling)
Follow-up
Study entry to stage 3 T1D onset
Methodological detailslongitudinal
  • Longitudinal

Primary result

As reported in the abstract

Yearly rate of decline in beta cell glucose sensitivity

<14 years

−13.7

median · IQR 21.2 · pmol min-1 m-2 [mmol/l]-1

≥14 years

−11.9

median · IQR 21.5 · pmol min-1 m-2 [mmol/l]-1

P = 0.52

Further findings

Median, ml min-1 m-2

Outcome<14 years≥14 yearsP value
Yearly rate of decline in insulin sensitivity · study entry to stage 3 T1D onsetNo significant difference−22 (IQR 37)−14 (IQR 40)P = 0.07

T1D risk by age (entire DPT-1 cohort)

Highest discriminant age for T1D risk
14 years
Participants aged <14 years twice as likely to progress to T1D as those aged ≥14 years

Beta cell glucose sensitivity at study entry

Impaired to a similar extent in progressors aged <14 and ≥14 years

Original publication

The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes. Diabetologia. Published 2 December 2022. doi:10.1007/s00125-022-05836-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.